Arkansas 2023 Regular Session

Arkansas House Bill HB1288

Introduced
1/26/23  
Refer
1/26/23  
Report Pass
2/16/23  
Engrossed
2/21/23  
Refer
2/21/23  
Report Pass
2/27/23  
Enrolled
3/1/23  
Chaptered
3/6/23  

Caption

To Make Technical Corrections To Title 20 Of The Arkansas Code Concerning Public Health And Welfare.

Impact

The most notable change introduced by HB1288 is the formalization of coverage for continuous glucose monitors in the Arkansas Medicaid Program for individuals with conditions such as type 1 diabetes or severe hypoglycemia. Additionally, the bill makes amendments to existing statutes regarding Hepatitis C screenings during pregnancy, ensuring clarity in the mandatory reporting protocols for the Department of Health. These adjustments are expected to improve healthcare delivery and accessibility for vulnerable populations, particularly those with chronic health conditions.

Summary

House Bill 1288 is a legislative measure introduced in Arkansas aimed at making technical corrections to Title 20 of the Arkansas Code, specifically related to public health and welfare. The bill addresses several amendments, including the definition and provision of coverage for continuous glucose monitors, which are critical medical devices for individuals with diabetes. By clarifying these provisions, the bill seeks to enhance the effectiveness of existing healthcare policies and ensure that individuals who meet specific medical criteria receive appropriate benefits under the Arkansas Medicaid Program.

Sentiment

The sentiment surrounding HB1288 is generally positive, with support from health advocates and medical professionals who view the bill as a necessary improvement to public health legislation. This aligns with broader efforts to enhance healthcare services and accessibility in Arkansas. Stakeholders appreciate the technical corrections as they reflect an understanding of the complex needs of patients requiring continuous monitoring and other essential health services.

Contention

While HB1288 has garnered support for its intended improvements, there may still be lingering concerns about the adequacy of Medicaid funding to cover the costs associated with expanded services. Opposition could arise from budgetary considerations or market reactions regarding how these changes will impact healthcare providers. Additionally, there may be discussions around the appropriate categorization of medical devices and their implications for state regulations concerning healthcare provisioning.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.